If pregnant female with 15 weeks with previous lscs . Mode of induction of delivery

Reading File
Finding Sources
Finding Sources
Searching PubMed

misoprostol mifepristone second trimester termination previous cesarean

Reading File
Finding Sources
Searching PubMed

second trimester abortion uterine scar safety

Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
I now have sufficient information to provide a thorough answer. Let me compile it.

Mode of Delivery/Induction at 15 Weeks with Previous LSCS

At 15 weeks gestation with a prior lower segment cesarean section (LSCS), the uterus is less than 28 weeks' size. Two main options exist: medical induction of labor and surgical evacuation (D&E). The choice must be individualized based on clinical indication, provider experience, and patient preference.

1. Surgical Option - Dilation and Evacuation (D&E)

D&E is the preferred method at 15 weeks when an experienced provider is available, for several reasons:
  • At 14-24 weeks, surgical termination has a lower overall complication rate (4%) compared to labor induction (29%)
  • Less risk of retained products of conception and method failure
  • Does NOT subject the uterine scar to repeated prostaglandin or oxytocin stimulation, reducing uterine rupture risk
  • Cost-effective and time-efficient
Preparation for D&E:
  • Cervical preparation with laminaria (osmotic dilators) placed 1-2 days before -- this is strongly associated with reduced D&E complications
  • Misoprostol 400 mcg vaginally 3 hours before the procedure is an alternative for cervical preparation
Note: D&E limits the ability to perform intact fetal autopsy, which may matter if the indication is fetal anomaly.

2. Medical Induction of Labor

For a previous low-transverse uterine incision with uterus < 28 weeks' size, the standard protocol is:

A. Mifepristone + Misoprostol (Preferred Medical Regimen)

  • Mifepristone 200 mg orally, followed 24-48 hours later by misoprostol
  • Misoprostol dosing at < 28 weeks' gestation:
    • 400 mcg vaginally or sublingually every 3-6 hours (usual protocols for < 28 weeks apply)
    • The 200 mcg vaginal dose may be preferred when a uterine scar is present (lower risk), especially between 24-28 weeks -- at 15 weeks, standard dosing can be used but with close monitoring
  • This combination significantly shortens induction-to-delivery interval

B. Misoprostol Alone

  • If mifepristone is unavailable: misoprostol 400 mcg vaginally/sublingually every 3-6 hours
  • Misoprostol is the most efficient method of induction at < 28 weeks, regardless of Bishop score

C. High-Dose Oxytocin

  • Acceptable alternative to misoprostol for induction < 28 weeks
  • Less efficient than misoprostol, but usable
Oxytocin alone at < 28 weeks is less preferred because the uterus is relatively oxytocin-insensitive before 28 weeks; however, it remains an option.

3. Repeat Cesarean Section

  • An option only if medically necessary (maternal indication), after careful risk-benefit discussion
  • Ideally avoided -- labor induction results in vaginal delivery in ~91% of women with prior cesarean who undergo induction for fetal demise/second-trimester cases
  • Women with a prior classic (vertical) uterine incision: repeat cesarean is the appropriate mode due to 1-12% uterine rupture risk

Key Risk: Uterine Rupture in Scarred Uterus

Incision TypeRisk with Medical Induction
Previous low-transverse LSCSLow but present; use reduced/standard misoprostol doses
Previous classic incision1-12% rupture risk -- repeat cesarean recommended
Previous low-vertical or unknownTreat as classic; repeat cesarean preferred
In the SCRN study, among women with prior cesarean who underwent labor induction for stillbirth, 91.1% delivered vaginally and 2 had uterine rupture (4.4%) -- highlighting that induction is feasible but requires close surveillance.

Summary Table

MethodPreferred at 15 Weeks + Prior LSCS?
D&E (surgical)Yes - first choice when experienced provider available
Mifepristone + MisoprostolYes - first-line medical option
Misoprostol aloneYes - acceptable
High-dose oxytocinYes - acceptable alternative
Repeat cesareanOnly if maternal indication; avoid if possible
Cervical Foley balloonUsed for scarred uterus > 28 weeks; not primary at 15 weeks

Bottom line: At 15 weeks with a previous LSCS (low-transverse), D&E is the safest surgical option with the lowest complication rate. If medical induction is chosen, the standard misoprostol protocol for < 28 weeks applies (400 mcg every 3-6 hours, vaginally or sublingually), with mifepristone pretreatment if available. The scar is not a contraindication to medical induction at this gestational age, but vigilance for uterine rupture is essential.
  • Creasy & Resnik's Maternal-Fetal Medicine, pp. 1007-1009 (Management section and "History of Previous Cesarean Delivery" box)

13 weeks

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I have enough from the textbook sources and the prior session's data. Here is the focused answer for 13 weeks:

Mode of Delivery/Termination at 13 Weeks with Previous LSCS

13 weeks sits at the late first trimester / early second trimester boundary. The uterus is well under 28 weeks' size. The prior LSCS scar influences the choice significantly because medical induction methods carry a small but real uterine rupture risk in a scarred uterus.

Preferred Method: Surgical Evacuation

Suction Evacuation (MVA / Electric Vacuum Aspiration) or D&E is the method of choice at 13 weeks with a previous LSCS, for these reasons:
  • At 13 weeks, suction/vacuum aspiration is still technically feasible (up to ~14 weeks for MVA; D&E for 13-24 weeks)
  • Surgical evacuation avoids all prostaglandin/oxytocin stimulation of the uterine scar, eliminating the risk of scar dehiscence or rupture
  • Overall complication rate for surgical termination at 13-24 weeks is ~4%, vs 29% for medical induction
  • No risk of uterine rupture from drug-induced contractions
Procedure steps:
  1. Cervical preparation (mandatory at 13 weeks before surgical evacuation):
    • Misoprostol 400 mcg vaginally 2-3 hours before procedure, OR
    • Osmotic dilators (laminaria) placed 1-2 days before - associated with lower complication rates
    • Mifepristone 200 mg orally 24 hours before (primes cervix, softens it)
  2. Suction/vacuum aspiration or D&E under local/general anesthesia
  3. Check completeness (clinical + ultrasound guided)

Medical Option (if surgical not available/refused)

If the patient declines surgery or surgical expertise is unavailable, mifepristone + misoprostol can be used:
DrugDoseRouteTiming
Mifepristone200 mgOralDay 1
Misoprostol400 mcgVaginal / sublingual24-48 hrs after mifepristone
Repeat misoprostol400 mcgVaginalEvery 3-6 hrs if needed (max 4-5 doses)
  • Standard dosing for < 28 weeks gestation applies
  • Close monitoring is mandatory - watch for signs of uterine scar dehiscence (abdominal pain out of proportion, maternal tachycardia, haematuria)
  • Success rate ~95% with mifepristone + misoprostol regimen
  • Misoprostol alone (without mifepristone) is less effective but acceptable
Oxytocin alone is less effective at 13 weeks (uterus relatively insensitive before 28 weeks) and is not a preferred first-line medical agent at this gestation.

Repeat Cesarean Section

  • Not recommended as a primary approach for termination at 13 weeks - unacceptable surgical risk for a non-viable pregnancy termination
  • Only considered if there is a genuine maternal indication making vaginal/transcervical approaches unsafe
  • Each repeat cesarean increases risk for placenta accreta spectrum in future pregnancies

Key Distinction: Type of Previous Uterine Scar

Previous IncisionRecommended Approach
Low-transverse LSCSSurgical evacuation (preferred) or mifepristone + misoprostol with monitoring
Classic (vertical) incisionSurgical evacuation strongly preferred; avoid medical induction (rupture risk 1-12%)
Unknown scar typeTreat as classic; surgical evacuation preferred

Summary

At 13 weeks + previous LSCS, the preferred mode is:
Surgical evacuation (suction/MVA or D&E) with prior cervical preparation - safest, lowest complication rate, avoids scar-stimulation risk entirely.
If medical management is chosen (patient preference or unavailability of surgery), use mifepristone 200 mg + misoprostol 400 mcg with close inpatient monitoring for scar complications.
  • Creasy & Resnik's Maternal-Fetal Medicine - Management of Stillbirth and Second Trimester Loss, pp. 1007-1009
  • Kaplan & Sadock's Comprehensive Textbook of Psychiatry - Fertility Control section
This is a shared conversation. Sign in to Orris to start your own chat.